Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Herbalife Expects Q3 Net Sales To Decline (4.5)% To 0% Y/Y; Revises FY24 Sales Growth Outlook To (3.5)% To +1.5% (Prior View 0% To +5%)

Author: Benzinga Newsdesk | July 31, 2024 04:40pm

Full-year 2024 guidance revised: net sales reduced, adjusted EBITDA raised, capital expenditures reaffirmed.

Posted In: HLF